Is PCSK9 Associated with Plasma Lipid Levels in a Sub-Saharan African Population of Patients with Obesity and Type 2 Diabetes?
Camille Maadjhou Mba,1 Wilfred Mbacham,1 Eugène Sobngwi,2,3 Jean Claude Mbanya2,3 1Department of Physiological Sciences/Biochemistry, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon; 2Department of Internal Medicine and Special...
Guardado en:
Autores principales: | Mba CM, Mbacham W, Sobngwi E, Mbanya JC |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f434a57d7ab94f53a3ada0d9931ebba8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effects of immunisation against PCSK9 in mice bearing melanoma
por: Amir Abbas Momtazi-Borojeni, et al.
Publicado: (2019) -
Loss of Hepatic Surf4 Depletes Lipid Droplets in the Adrenal Cortex but Does Not Impair Adrenal Hormone Production
por: Xiaole Chang, et al.
Publicado: (2021) -
PCSK9 Gene Polymorphisms Associated With the Risk of Myocardial Infarction in Iranian Patients
por: Farshad Namordizadeh, et al.
Publicado: (2021) -
Safety and Tolerability of PCSK9 Inhibitors: Current Insights
por: Kosmas CE, et al.
Publicado: (2020) -
Acaudina molpadioides mediates lipid uptake by suppressing PCSK9 transcription and increasing LDL receptor in human liver cells
por: Allicia Jack, et al.
Publicado: (2021)